- Home
- ATOS vs MDIA Comparison
ATOS vs MDIA Comparison
Compare ATOS & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- MDIA
- Stock Information
- Founded
- ATOS 2009
- MDIA 2019
- Country
- ATOS United States
- MDIA United States
- Employees
- ATOS N/A
- MDIA N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- MDIA Broadcasting
- Sector
- ATOS Health Care
- MDIA Consumer Discretionary
- Exchange
- ATOS Nasdaq
- MDIA Nasdaq
- Market Cap
- ATOS 120.4M
- MDIA 102.4M
- IPO Year
- ATOS 2012
- MDIA N/A
- Fundamental
- Price
- ATOS $0.86
- MDIA $1.05
- Analyst Decision
- ATOS Strong Buy
- MDIA
- Analyst Count
- ATOS 3
- MDIA 0
- Target Price
- ATOS $6.25
- MDIA N/A
- AVG Volume (30 Days)
- ATOS 1.3M
- MDIA 31.4K
- Earning Date
- ATOS 11-12-2025
- MDIA 11-13-2025
- Dividend Yield
- ATOS N/A
- MDIA N/A
- EPS Growth
- ATOS N/A
- MDIA N/A
- EPS
- ATOS N/A
- MDIA 0.40
- Revenue
- ATOS N/A
- MDIA $121,938,000.00
- Revenue This Year
- ATOS N/A
- MDIA N/A
- Revenue Next Year
- ATOS N/A
- MDIA N/A
- P/E Ratio
- ATOS N/A
- MDIA $2.67
- Revenue Growth
- ATOS N/A
- MDIA 165.75
- 52 Week Low
- ATOS $0.55
- MDIA $0.79
- 52 Week High
- ATOS $1.66
- MDIA $1.90
- Technical
- Relative Strength Index (RSI)
- ATOS 39.96
- MDIA 26.37
- Support Level
- ATOS $0.86
- MDIA $1.11
- Resistance Level
- ATOS $0.91
- MDIA $1.26
- Average True Range (ATR)
- ATOS 0.05
- MDIA 0.05
- MACD
- ATOS -0.02
- MDIA -0.02
- Stochastic Oscillator
- ATOS 4.01
- MDIA 4.17
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.